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254a Monday, February 4, 2013We conclude that the two strands are effectively stapled together through a large
number of weak bonds involving T4 ligase. The absence of a similarly strong
transformation of DNA in free solution points towards the necessity of parallel
pre-alignment through the nanotube. We point to the fact that the formation of
hairpins and the 1-d scanning of strands past each other solves the kinetic prob-
lem of forming a loop in a maze-like environment.
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Integration Host Factor (IHF) is a heterodimeric DNA-binding protein pro-
duced by E.coli. IHF interacts with the minor groove and phosphodiester back-
bone of the DNA to create sharp bends in the DNA and is often referred to as an
architectural protein. Although the protein binds sequence-specifically, it also
recognizes DNA conformation. Prokaryotic cellular processes involving IHF
include viral integration, replication and activation of gene expression.
We have recently shown that IHF exhibits high binding affinity for the Holliday
or four-way junction DNA (4WJ), an intermediate in homologous recombina-
tion where strands from different chromosomes cross over. Fo¨rster Resonance
Energy Transfer (FRET), where the 5’-ends of DNA strands are labeled with
fluorophores, is used to determine the conformational changes of the 4WJ
when interacting with DNA-binding proteins. These measurements have shown
that the 4WJ opens upon binding with IHF, which is consistent with data pro-
moting the protein’s involvement in recombinase action. Subsequent FRET ex-
periments performed confirm this observation, and provide a value for the
efficiency of binding and the degree of distortion induced.
Interactions between IHF and the cos I1 site of DNA from the lambda bacterio-
phage will also be explored. It is known that IHF induces bending at cos sites.
The affinity of binding to D cos DNA is compared to that between IHF and its
consensus sequence (H1) in E. coli DNA. Gel mobility shift assay (GMSA) and
solutions experiments will measure the binding and affinity of IHF with the cos
I1 site. FRET experiments with labeled cosI1 DNA will reveal the distortion
induced upon IHF binding and these results will be compared to those with
IHF binding to the H1 site.
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RNA aptamers are structured single-stranded oligonucleotides that specifically
bind to a broad spectrum of biomolecular targets with as tight as pM affinity.
The structural stability and diverse functionality of aptamers have enabled their
use as diagnostic tools, inhibitors and potential therapeutic agents. However,
a detailed understanding of how aptamers specifically bind to selected regions
on the surface of proteins and cells lags significantly behind advances in their
applications. Solving a high resolution RNA aptamer structure by crystallo-
graphic or spectroscopic methods require minimizing the aptamer into a com-
pact form. We show that aptamers can be effectively minimized for structural
analysis using chemical mapping to experimentally define the secondary struc-
ture and identify tertiary contacts within the RNA and with the target protein.
Ribonuclease and SHAPE mapping were used to determine the correct pre-
dicted secondary structure of a high affinity aptamer (Lys1) selected against
hen egg white lysozyme (KD ~ 30 nM). A deletion variant, minE, was engi-
neered to delete a long apparently unstructured region. Binding assays indicate
comparable affinity of lysozyme against minE, KD ~ 20 nM. The lysozyme-
minE complex was solved by x-ray crystallography at 2.0 A˚ resolution yielding
a seventh RNA aptamer-protein structure. Solution hydroxyl-radical footprint-
ing confirms the binding interface observed in the crystal. The minE aptamer
interacts with a basic face of lysozyme, which is located opposite from the cat-
alytic residues Asp52 and Glu35. The minE aptamer inhibits the function of
lysozyme in vitro. The binding of minE distant from the catalytic site suggests
that the aptamer inactivates lysozyme allosterically. The long term goal of this
study is to develop a systematic approach to aptamer minimization and use
solved structures to probe the mechanisms by which RNA aptamers bind their
targets and regulate catalytic activity and/or cellular function.
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Minneapollis, MN, USA.The human immunodeficiency virus type 1 (HIV-1) Gag protein is essential
for retroviral assembly. During viral maturation, Gag is processed to form
matrix (MA), capsid (CA), and nucleocapsid (NC). Mature NCp7 is derived
from processing of NCp15 and NCp9. NCp7 functions as a nucleic acid
chaperone during retroviral replication, in which it rearranges nucleic acids
to facilitate reverse transcription and recombination. In this work, we used
single-molecule DNA stretching to probe the interactions of these proteins
with DNA. Using this technique, we have previously shown that NCp7
destabilizes DNA with rapid kinetics, yielding almost reversible force-
extension curves. NCp7 intercalates into dsDNA to keep the two single
strands close together while destabilizing them. Surprisingly, multiple stretch
and release cycles of DNA in the presence of NCp7 yields changing force-
extension curves on the time scale of tens of minutes. If the NCp7 solution
is rinsed from the buffer surrounding the DNA molecule, we find that
some fraction of the bound protein does not dissociate. The protein only dis-
sociates completely when competitor DNA is introduced to the solution sur-
rounding the stretched DNA molecule. Thus, NCp7 exhibits binding modes
on multiple time scales, including both rapid microscopic and slow macro-
scopic dissociation rates. To test the origin of this surprising behavior
and understand how NC-DNA interactions are regulated, we will also apply
these methods to NCp9 and NCp15 interactions with DNA. Further studies
will elucidate the kinetics of these protein-DNA interactions. This work
was funded in part by Federal Funds from NCI, NIH under contract
HHSN261200800001E (RJG).
1305-Pos Board B197
Controlling Drug Resistance in Fungal Systems by Zinc Cluster Proteins
Kari J. Tanaka, Heather W. Pinkett.
Northwestern University, Evanston, IL, USA.
Drug resistance is a serious complication for patients with an infection, and
unfortunately, bacteria and fungi are quickly rendering many therapeutic drugs
ineffective. In Saccharomyces cerevisiae, this mechanism is defined as pleio-
tropic drug-resistance (PDR). Overexpression of drug efflux pumps, which
transport drugs out of the cell, is controlled by two major transcriptional reg-
ulators, Pdr1p and Pdr3p. Homologous PDR pathways have been identified in
other pathogenic species, such as Canadida albicans. Pdr1p and Pdr3p are zinc
cluster transcription factors that recognize a pair of CGG repeats in the pro-
moter region of target PDR genes. Interestingly, these transcriptional regula-
tors tolerate sequence variation within the binding site and recognize a small
group of variant sites. Pdr1p and Pdr3p have been shown to selectively regulate
PDR genes through canonical and variant binding sites. This is observed in the
differential regulation of two PDR genes: PDR5, the prominent ABC trans-
porter and HXT11, a hexose transporter. Pdr1p and Pdr3p recognize a variant
binding site in the promoter region of PDR5; however, the transcriptional
regulators do not recognize the same variant site in the promoter of HXT11.
The regulatory mechanism for how canonical and variant binding sites lead
to differential PDR gene expression has yet to be explored. These protein/
DNA interactions have been studied using two approaches, binding
affinity and specificity studies. Fluorescence anisotropy and surface plasmon
resonance were used to determine the individual binding affinities of the
DNA-binding domain (DBD) for canonical and variant binding sites, and
x-ray crystallography was utilized to resolve the molecular interactions
between the DBD complex with canonical and variant binding sites. Differ-
ences in the binding motifs and in the DBDs of Pdr1p and Pdr3p must allow
for differential regulation, making this a unique system for investigation and
a possible drug target.
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Specific inhibition or activation of enzymes and other proteins with small
molecules is a widely exploited approach to modulating cellular pathways.
Targeting the expression of these proteins at the level of transcription has
remained relatively unexplored, however, and may offer significant biotechno-
logical and therapeutic potential. We are interested in pharmacological modu-
lation of genes controlled by members of the ETS family of transcription
factors. ETS proteins are widely distributed among metazoan phyla and regu-
late a functionally diverse array of genes. As a model system, we have charac-
terized the inhibition of sequence-specific binding of the ETS domain of PU.1
(Spi-1) to a natural high-affinity site by distamycin. Using previously estab-
lished thermodynamic data on this protein-DNA system, we have refined the
experimental conditions for surface-plasmon resonance (SPR) overcome
